Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50

34 of the most innovative pharmaceutical products

By Brian Buntz | July 21, 2021

innovative pharmaceutical products pharmaceuticals

Photo by Myriam Zilles on Unsplash

The Galien Foundation has revealed its latest nominees for the 2021 Prix Galien USA Award highlighting innovations in biotechnology, pharmaceutical agents, medical technology and digital health products.

Entrants to the competition must have received FDA approval within the past five years and demonstrate exceptional therapeutic potential. The Galien Foundation does not use financial data to make its selections.

The organization will announce the final competition winners at a ceremony in New York City on Oct. 28, 2021. 

[Related: The most innovative pharmaceutical agents of 2020] 

In terms of pharmaceutical agents, the organization selected the following 34 nominees:

Company

Drug name

AbbVie Inc.

Rinvoq (upadacitinib)

Adlon Therapeutics L.P., a subsidiary of Purdue Pharma 

Adhansia XR (methylphenidate HCI)

Advanced Accelerator Applications USA, Inc., a Novartis company

Lutathera (lutetium Lu 177 dotatate)

Astellas Pharma Inc.

Xospata  (gilteritinib)

Bayer U.S., LLC

Nubeqa (darolutamide)

Bayer U.S., LLC

Vitrakvi  (larotrectinib)

Biohaven Pharmaceuticals

Nurtec ODT (rimegepant)

Blueprint Medicines

Ayvakit (avapritinib)

Blueprint Medicines

Gavreto (pralsetinib)

Deciphera Pharmaceuticals

Qinlock (ripretinib)

Eiger BioPharmaceuticals, Inc.

Zokinvy (lonafarnib)

Eli Lilly & Company

Olumiant (baricitinib)

Eli Lilly & Company

Reyvow (lasmiditan)

Epizyme Inc.

Tazverik (tazemetostat)

Esperion Therapeutics Inc.

Nexlizet (bempedoic acid and ezetimibe)

Esperion Therapeutics Inc.

Nexletol (bempedoic acid)

Genentech, a member of the Roche Group

Rozlytrek (entrectinib)

Gilead Sciences, Inc.

Veklury (remdesivir)

Incyte

Pemazyre (pemigatinib)

Karyopharm Therapeutics Inc.

Xpovio (selinexor)

Medicines Development for Global Health

Moxidectin

Merck & Co., Inc.

Recarbrio (imipenem, cilastatin and relebactam)

Myovant Sciences, Inc.

Orgovyx (relugolix)

Novartis Pharmaceuticals Corporation

Adakveo (crizanlizumab)

Novartis Pharmaceuticals Corporation

Entresto (sacubitril/valsartan)

Novartis Pharmaceuticals Corporation

Piqray (alpelisib)

Pfizer Inc.

Braftovi Mektovi (encorafenib/binimetinib)

Pfizer Inc.

Lorbrena (lorlatinib)

Population Council

Annovera (segesterone acetate and ethinyl estradiol)

Seagen

Tukysa (tucatinib)

Servier Pharmaceuticals

Asparlas (calaspargase pegol-mknl injection)

SIGA Technologies, Inc.

Tpoxx (tecovirimat)

Sobi, Inc.

Gamifant (emapalumab-lzsg)

Dr. Reddy’s Laboratories, Inc.

Elyxyb (celecoxib)


Filed Under: Cardiovascular, Dermatology, Drug Discovery, Infectious Disease, Neurological Disease, Oncology, Rheumatology
Tagged With: AbbVie, Adakveo, Adhansia XR, Adlon Therapeutics, Advanced Accelerator Applications, Asparlas, Astellas Pharma, AYVAKIT, Bayer, Biohaven Pharmaceuticals, Blueprint Medicines, Braftovi Mektovi, Deciphera Pharmaceuticals, Dr. Reddy's Laboratories, Eiger BioPharmaceuticals, Eli Lilly, ELYXYB, Entresto, Epizyme Inc., Esperion Therapeutics, Gamifant, GAVRETO, Genentech, Gilead Sciences, Incyte, Karyopharm Therapeutics, Lorbrena, Lutathera, Merck, Moxidectin, Myovant Sciences, NEXLETOL, NEXLIZET, Novartis, NUBEQA, Nurtec ODT, Olumiant, Orgovyx, Pemazyre, Pfizer, PIQRAY, Purdue Pharma, QINLOCK, RECARBRIO, remdesivir, REYVOW, Rinvoq, Roche, Rozlytrek, Seagen, Servier Pharmaceuticals, SIGA, Sobi, TAZVERIK, TPOXX, Tukysa, Veklury, VITRAKVI, XOSPATA, XPOVIO, ZOKINVY
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Lab facility
Massachusetts is competing for ARPA-H biomedical research center
Blockchain
Startup vies to get blockchain adoption in pharma off the ground
Black Diamond Therapeutics
Black Diamond analysis highlights 22 new oncogenic HER2 driver mutations
NIH National Institutes of Health
NIH licenses COVID-19 research technologies to WHO initiative

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50